​

Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SYK Stock Forecast

Stryker (SYK) stock forecast, based on 48 Wall Street analysts, predicts a 12-month average price target of $420.00, with a high of $450.00 and a low of $400.00. This represents a 21.21% increase from the last price of $346.50.

$250 $290 $330 $370 $410 $450 High: $450 Avg: $420 Low: $400 Last Closed Price: $346.5

SYK Stock Rating

Stryker stock's rating consensus is Buy, based on 48 Wall Street analysts. The breakdown includes 1 Strong Buy (2.08%), 34 Buy (70.83%), 13 Hold (27.08%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 48 13 34 1 Strong Sell Sell Hold Buy Strong Buy

SYK Price Target Upside V Benchmarks

TypeNameUpside
StockStryker21.21%
SectorHealthcare Stocks 35.25%
IndustryMedical Device Stocks21.20%

Price Target Trends

1M3M12M
# Anlaysts1318
Avg Price Target$403.00$425.00$394.83
Last Closing Price$346.50$346.50$346.50
Upside/Downside16.31%22.66%13.95%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 259139-132
Mar, 2591391-32
Feb, 2591391-32
Jan, 2591391133
Dec, 2491310-133
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 14, 2025Ryan ZimmermanBTIG$403.00$353.4214.03%16.31%
Mar 04, 2025Goldman Sachs$422.00$389.928.23%21.79%
Feb 03, 2025David ToungArgus Research$450.00$391.1415.05%29.87%
Dec 18, 2024Richard NewitterTruist Financial$409.00$359.1713.87%18.04%
Dec 02, 2024Patrick WoodMorgan Stanley$445.00$390.9013.84%28.43%
Oct 31, 2024Joanne WuenschCitigroup$411.00$363.4313.09%18.61%
Oct 30, 2024Matt O'BrienPiper Sandler$420.00$367.9514.15%21.21%
Oct 30, 2024Richard NewitterTruist Financial$380.00$365.423.99%9.67%
Oct 30, 2024Kyle RoseCanaccord Genuity$400.00$359.0111.42%15.44%
Oct 30, 2024Ryan ZimmermanBTIG$394.00$359.019.75%13.71%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 14, 2025BTIGBuyBuyhold
Jan 29, 2025Goldman SachsNeutralNeutralhold
Jan 29, 2025Deutsche BankHoldHoldhold
Jan 29, 2025BTIGBuyBuyhold
Jan 08, 2025BernsteinOutperformOutperformhold
Jan 02, 2025Evercore ISIOutperformOutperformhold
Dec 11, 2024RBC CapitalOutperformOutperformhold
Dec 11, 2024CitigroupBuyBuyhold
Oct 31, 2024BarclaysOverweightOverweighthold
Oct 31, 2024CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$4.26$5.29$6.23$8.34$7.86-----
Avg Forecast$7.18$9.11$9.18$10.41$12.05$13.49$14.92$16.63$18.36$20.61
High Forecast$7.25$9.20$9.30$10.45$12.09$13.62$15.22$17.86$18.71$21.00
Low Forecast$7.07$8.97$9.05$10.37$12.02$13.28$14.60$15.65$18.00$20.20
Surprise %-40.67%-41.93%-32.14%-19.88%-34.77%-----

Revenue Forecast

$10B $15B $20B $25B $30B $35B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$14.35B$17.11B$18.45B$20.50B$22.59B-----
Avg Forecast$14.42B$17.06B$18.21B$20.28B$22.52B$24.46B$26.37B$28.62B$31.09B$33.43B
High Forecast$14.52B$17.18B$18.40B$20.41B$22.64B$24.75B$26.89B$28.69B$31.54B$33.92B
Low Forecast$14.25B$16.86B$18.02B$20.23B$22.43B$24.17B$25.98B$28.54B$30.61B$32.91B
Surprise %-0.47%0.29%1.32%1.05%0.32%-----

Net Income Forecast

$500M $2B $4B $5B $7B $9B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.60B$1.99B$2.36B$3.17B$2.99B-----
Avg Forecast$1.22B$1.98B$2.16B$3.17B$4.63B$5.16B$5.72B$6.43B$7.05B$7.91B
High Forecast$1.49B$2.38B$2.59B$3.80B$4.64B$5.23B$5.84B$6.85B$7.18B$8.06B
Low Forecast$947.71M$1.59B$1.73B$2.53B$4.61B$5.10B$5.60B$6.01B$6.91B$7.75B
Surprise %31.14%0.47%9.14%--35.32%-----

SYK Forecast FAQ

Is Stryker stock a buy?

Stryker stock has a consensus rating of Buy, based on 48 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 34 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Stryker is a favorable investment for most analysts.

What is Stryker's price target?

Stryker's price target, set by 48 Wall Street analysts, averages $420 over the next 12 months. The price target range spans from $400 at the low end to $450 at the high end, suggesting a potential 21.21% change from the previous closing price of $346.5.

How does Stryker stock forecast compare to its benchmarks?

Stryker's stock forecast shows a 21.21% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical device stocks industry (21.20%).

What is the breakdown of analyst ratings for Stryker over the past three months?

  • April 2025: 28.12% Strong Buy, 40.62% Buy, 28.12% Hold, 0% Sell, 3.12% Strong Sell.
  • March 2025: 28.12% Strong Buy, 40.62% Buy, 28.12% Hold, 3.12% Sell, 0% Strong Sell.
  • February 2025: 28.12% Strong Buy, 40.62% Buy, 28.12% Hold, 3.12% Sell, 0% Strong Sell.

What is Stryker’s EPS forecast?

Stryker's average annual EPS forecast for its fiscal year ending in December 2025 is $13.49, marking a 71.63% increase from the reported $7.86 in 2024. Estimates for the following years are $14.92 in 2026, $16.63 in 2027, $18.36 in 2028, and $20.61 in 2029.

What is Stryker’s revenue forecast?

Stryker's average annual revenue forecast for its fiscal year ending in December 2025 is $24.46B, reflecting a 8.25% increase from the reported $22.6B in 2024. The forecast for 2026 is $26.37B, followed by $28.62B for 2027, $31.09B for 2028, and $33.43B for 2029.

What is Stryker’s net income forecast?

Stryker's net income forecast for the fiscal year ending in December 2025 stands at $5.16B, representing an 72.46% increase from the reported $2.99B in 2024. Projections indicate $5.72B in 2026, $6.43B in 2027, $7.05B in 2028, and $7.91B in 2029.